- Home
- SDOT vs CYCN Comparison
SDOT vs CYCN Comparison
Compare SDOT & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- CYCN
- Stock Information
- Founded
- SDOT 2014
- CYCN 2018
- Country
- SDOT United States
- CYCN United States
- Employees
- SDOT N/A
- CYCN N/A
- Industry
- SDOT Restaurants
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- SDOT Consumer Discretionary
- CYCN Health Care
- Exchange
- SDOT Nasdaq
- CYCN Nasdaq
- Market Cap
- SDOT 7.6M
- CYCN 7.6M
- IPO Year
- SDOT 2020
- CYCN N/A
- Fundamental
- Price
- SDOT N/A
- CYCN $2.52
- Analyst Decision
- SDOT
- CYCN
- Analyst Count
- SDOT 0
- CYCN 0
- Target Price
- SDOT N/A
- CYCN N/A
- AVG Volume (30 Days)
- SDOT 58.7K
- CYCN 1.1M
- Earning Date
- SDOT 11-11-2025
- CYCN 11-13-2025
- Dividend Yield
- SDOT N/A
- CYCN N/A
- EPS Growth
- SDOT N/A
- CYCN N/A
- EPS
- SDOT 6.14
- CYCN N/A
- Revenue
- SDOT $667,695,000.00
- CYCN $2,174,000.00
- Revenue This Year
- SDOT $12.76
- CYCN N/A
- Revenue Next Year
- SDOT $5.54
- CYCN N/A
- P/E Ratio
- SDOT $0.89
- CYCN N/A
- Revenue Growth
- SDOT 7.00
- CYCN N/A
- 52 Week Low
- SDOT $5.25
- CYCN $1.27
- 52 Week High
- SDOT $57.00
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- SDOT 59.90
- CYCN 47.81
- Support Level
- SDOT $5.62
- CYCN $2.17
- Resistance Level
- SDOT $6.22
- CYCN $2.56
- Average True Range (ATR)
- SDOT 0.49
- CYCN 0.33
- MACD
- SDOT -0.21
- CYCN -0.01
- Stochastic Oscillator
- SDOT 21.35
- CYCN 18.12
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.